📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Translating SOD1 Gene Silencing toward the Clinic: A Highly Efficacious, Off-Target-free, and Biomarker-Supported Strategy for fALS (2018)

First Author: Iannitti T

Attributed to: Identifying the transcriptomic basis underlying individualised drug response: moving towards personalised medicine in motor neurone disease (MND) usin funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.omtn.2018.04.015

PubMed Identifier: 30195799

Publication URI: http://europepmc.org/abstract/MED/30195799

Type: Journal Article/Review

Parent Publication: Molecular Therapy - Nucleic Acids

ISSN: 2162-2531